Pharmaceutical & Biotech
Pfizer-BioNTech, Moderna and Johnson & Johnson Ramp Up COVID-19 Vaccines for U.S. Population, an Industrial Info Market Brief
Pfizer Corporation-BioNTech, Johnson & Johnson and Moderna are fervently producing COVID-19 vaccines for the U.S. population.
Released Thursday, March 25, 2021
Reports related to this article:
Pfizer Corporation-BioNTech, Johnson & Johnson and Moderna are fervently producing COVID-19 vaccines for the U.S. population. Pfizer-BioNTech is primarily producing the vaccine at Pfizer's facility in Kalamazoo, Michigan. Moderna and Johnson & Johnson are contracting out much of their COVID-19 vaccine manufacturing to Catalent, using its facility in Bloomington, Indiana.
As of March 23, about one in four Americans had received at least their first COVID-19 vaccine dose.
Want More IIR News Intelligence?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Forecasts & Analytical Solutions
Where global project and asset data meets advanced analytics for smarter market sizing and forecasting.
Explore Our SolutionsRelated Articles
-
Novo Nordisk Spends $11 Billion to Make More Weight Loss Dru...February 15, 2024
-
Industrial Manufacturing Leads Michigan to $7.5 Billion in P...August 16, 2022
-
EU Adds New COVID-19 Manufacturing CapacitySeptember 07, 2021
-
Global Pharma-Bio Industry Boasts More Than $87 Billion in P...December 02, 2019
-
Catalent Amps Up Contract Biological Manufacturing Capacity ...January 08, 2019
PECWeb Global Market Intelligence Platform
Identify opportunities, anticipate change, and execute with confidence. PECWeb connects the industrial intelligence you need, from projects and assets to operational events, all in one platform.
Discover PecwebIndustry Intel
-
Latin America Data Center Outlook 2026: Power, Hubs & GrowthPodcast Episode / Oct 9, 2026
-
Food and Beverage CapEx Outlook 2026: Tariffs, AI, AfricaPodcast Episode / Oct 9, 2026
-
North America Refining 2026: New Pipelines to PADD 5Podcast Episode / Oct 2, 2026
-
Biomanufacturing Onshoring 2026: GLP-1, CDMO and ReshoringPodcast Episode / Oct 2, 2026
-
2026 US Data Center Outlook: Power, Land & CoolingPodcast Episode / Sep 18, 2026